AZGP1 and polycystic ovary syndrome: Moreover, serum ZAG levels have been found to be decreased in various obesity-related disorders, including T2DM (36), hypertension (39), premature coronary artery disease (50), and PCOS (41), which further indicates the pivotal role of ZAG in the regulation of metabolism.